Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Ophthalmology
•
Vitreoretinal Diseases and Surgery
When should methotrexate injections be initiated for proliferative vitreoretinopathy?
Related Questions
What factors influence the decision to initiate anti-VEGF injections to prevent radiation retinopathy after plaque brachytherapy?
Do you routinely recommend IV systemic antibiotic therapy in additional to intravitreal antibiotic therapy for exogenous bacterial endophthalmitis?
How do you decide on when to start or continue anti-VEGF injections during pregnancy?
How should diabetic retinopathy surveillance be adjusted for patients starting GLP-1 agonists?
When should delayed removal of an intraocular foreign body be considered?
How do you manage a situation where the lens optic shifts in front of the iris after a Yamane technique?
What factors guide the decision to treat with ROP laser treatment versus a repeat anti-VEGF injection in a child who has previously received anti-VEGF therapy for retinopathy of prematurity (ROP)?
How do you manage macular-threatening toxoplasma chorioretinitis in pregnancy?
How do you manage cystoid macular edema (CME) in patients with steroid-induced intraocular hypertension that is resistant to topical treatments?
Do you utilize thrombolytic therapy in patients with CRAO?
